Anivance AI Corporation
Update：2026/08/06
Industries
Main Industry
Biotechnology
Founded Year
2024
Unified Business No.
95464296
Status
Active
Number of Employees
20
Total Paid-in
Capital
26,130,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Anivance AI is transforming biomedical research by integrating organ-on-a-chip technology with human data-driven AI. Its platform combines human organ chips and advanced computational modeling to create digital twins, providing an alternative to traditional animal testing. By using patient-derived cells to build micro-organs, the system enables highly personalized simulation of drug responses. This approach improves predictive accuracy, shortens drug development timelines, and supports more ethical, data-driven research. By bridging biology and artificial intelligence, Anivance AI is positioning itself as a next-generation medical testing platform for precision medicine and pharmaceutical innovation.
